Ontology highlight
ABSTRACT:
INSTRUMENT(S): LTQ Orbitrap Elite
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Urinary Bladder, Bladder Urothelial Cell
DISEASE(S): Bladder Transitional Cell Carcinoma
SUBMITTER: Thilo Bracht
LAB HEAD: Barbara Sitek
PROVIDER: PXD009203 | Pride | 2019-08-13
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
OEI17245.mgf | Mgf | |||
OEI17245.msf | Msf | |||
OEI17245.mzid.gz | Mzid | |||
OEI17245.pride.mgf.gz | Mgf | |||
OEI17245.pride.mztab.gz | Mztab |
Items per page: 5 1 - 5 of 122 |
Witzke Kathrin E KE Großerueschkamp Frederik F Jütte Hendrik H Horn Melanie M Roghmann Florian F von Landenberg Nicolas N Bracht Thilo T Kallenbach-Thieltges Angela A Käfferlein Heiko H Brüning Thomas T Schork Karin K Eisenacher Martin M Marcus Katrin K Noldus Joachim J Tannapfel Andrea A Sitek Barbara B Gerwert Klaus K
The American journal of pathology 20190212 3
Histopathological differentiation between severe urocystitis with reactive urothelial atypia and carcinoma in situ (CIS) can be difficult, particularly after a treatment that deliberately induces an inflammatory reaction, such as intravesical instillation of Bacillus Calmette-Guèrin. However, precise grading in bladder cancer is critical for therapeutic decision making and thus requires reliable immunohistochemical biomarkers. Herein, an exemplary potential biomarker in bladder cancer was identi ...[more]